Purchase Order W81K0022P0175

This firm fixed-price purchase order was awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical devices and assays. The contract, valued at $122,850.00, is for the delivery of EG2 Combo STEC Assay kits, which are used to test for dangerous E.coli strains. Rokabio has previously provided the Army and other DoD agencies with automated molecular detection instruments, assay reagents, and...

This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical devices and assay reagents. The $160,699.00 contract funds the delivery of the company's specialized EG2 STEC assay kits and related consumables, including reagents, controls, transfer tubes, and other ancillary items, to support the Department of Defense's Food Analysis and Diagnostic Laboratory...

This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit woman-owned manufacturer. The one-year contract, valued at $275,725.00, is for the delivery of chemistry reagents. Rokabio provides specialized medical devices, assay kits, and related services to support Department of Defense health agencies and military medical readiness programs. Past federal contracts indicate the company has...

This federal contract award is for the ROKA ATLAS SYSTEM, a purchase order contract valued at $82,808.17 awarded to Rokabio Inc., a for-profit, woman-owned manufacturer of medical diagnostics and analytical laboratory instruments. The contract, which has a firm fixed price and ultimate completion date of August 16, 2024, was awarded on July 4, 2019 by the Food and Drug Administration, a civilian agency. The contract does not have a set-aside designation. Rokabio Inc., doing business as Roka...

This is a $96,000.00 firm fixed-price purchase order contract awarded by the Medical Command (MEDCOM) of the U.S. Department of the Army to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical diagnostics and analytical instruments. The contract is for the delivery of the ATLAS System, a specialized molecular detection instrument used to rapidly identify pathogens and bacteria, primarily in support of the Department of Defense's Food Analysis and...

This firm fixed price purchase order was awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, for annual preventive maintenance. The $82,850 contract will provide preventive maintenance services at the place of performance in San Antonio, TX from October 2018 through October 2023. The original solicitation sought annual preventive maintenance as described, with the award resulting from the "Annual Preventive Maintenance" solicitation...

<p>Roche Diagnostics Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at $24,585.95 by the Defense Health Agency to provide COBAS assays. The contract has no set-aside designation and requires completion by September 30, 2022. As the sole awardee, Roche Diagnostics will deliver the requested laboratory testing products from its location in Castleton, Indiana to support the Defense Health Agency's medical diagnostic services.</p>

<p>Roche Diagnostics Corporation has been awarded a $17,745 firm fixed price delivery order contract by the Defense Health Agency to provide KAPA KITS FOR CASEWORK. The contract has no set-aside designation and runs through September 30, 2023. The kits will support the Agency's medical laboratory casework programs. Roche Diagnostics will perform as the prime contractor, with work taking place in Castleton, Indiana.</p>

Roche Diagnostics Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency valued at $21,139.67 to provide COBAS assays. The contract has no set-aside designation and requires completion by September 30, 2022. As the prime contractor, Roche Diagnostics will deliver the requested laboratory testing products from their facility located in Castleton, Indiana to support the broader health programs overseen by the Defense Health...

Roche Diagnostics Corporation was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on April 15, 2022. The contract has a potential value of $24,999.55 to provide COBAS assays with no set-aside designation applied. Performance will occur in Castleton, Indiana through September 30, 2022. As the healthcare arm of the Department of Defense, this award supports the Defense Health Agency's mission to provide health care support and services to...